Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
Tectonic Therapeutic (NASDAQ: TECX), a clinical stage biotech company specializing in G-protein coupled receptors (GPCRs), has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The event will take place in New York from December 3-5, 2024. Alise Reicin, MD, President and CEO, will deliver a presentation on Tuesday, December 3rd, 2024, at 12:30 PM ET.
The presentation will include one-on-one meetings and will be accessible via webcast. Interested parties can access the live webcast through the Investors section of Tectonic's website, where a replay will remain available for approximately 90 days after the conference.
Tectonic Therapeutic (NASDAQ: TECX), un'azienda biotech in fase clinica specializzata in recettori accoppiati alle proteine G (GPCR), ha annunciato la sua partecipazione alla 36ª Conferenza Annuale sulla Salute di Piper Sandler. L'evento si svolgerà a New York dal 3 al 5 dicembre 2024. Alise Reicin, MD, Presidente e CEO, presenterà martedì 3 dicembre 2024, alle 12:30 ET.
La presentazione includerà incontri individuali e sarà accessibile tramite webcast. Le parti interessate possono accedere al webcast in diretta attraverso la sezione Investitori del sito web di Tectonic, dove sarà disponibile un replay per circa 90 giorni dopo la conferenza.
Tectonic Therapeutic (NASDAQ: TECX), una empresa biotecnológica en fase clínica especializada en receptores acoplados a proteínas G (GPCR), ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. El evento se llevará a cabo en Nueva York del 3 al 5 de diciembre de 2024. Alise Reicin, MD, Presidenta y CEO, dará una presentación el martes 3 de diciembre de 2024, a las 12:30 PM ET.
La presentación incluirá reuniones individuales y será accesible a través de un webcast. Las partes interesadas pueden acceder al webcast en vivo a través de la sección de Inversores del sitio web de Tectonic, donde se mantendrá disponible una repetición durante aproximadamente 90 días después de la conferencia.
Tectonic Therapeutic (NASDAQ: TECX)는 G 단백질 결합 수용체 (GPCR)를 전문으로 하는 임상 단계 생명공학 회사로, Piper Sandler 제36회 연례 건강 회의에 참여한다고 발표했습니다. 이 행사는 2024년 12월 3일부터 5일까지 뉴욕에서 열릴 예정이며, Alise Reicin, MD 대표이사 겸 사장이 2024년 12월 3일 화요일 오후 12시 30분 ET에 발표를 진행합니다.
발표에는 일대일 미팅이 포함될 것이며, 웹캐스트를 통해 접근할 수 있습니다. 관심 있는 당사자는 Tectonic 웹사이트의 투자자 섹션을 통해 실시간 웹캐스트에 접근할 수 있으며, 회의 후 약 90일간 다시 볼 수 있습니다.
Tectonic Therapeutic (NASDAQ: TECX), une entreprise biotechnologique en phase clinique spécialisée dans les récepteurs couplés aux protéines G (GPCR), a annoncé sa participation à la 36e Conférence Annuelle de Santé de Piper Sandler. L'événement se déroulera à New York du 3 au 5 décembre 2024. Alise Reicin, MD, Présidente et CEO, fera une présentation le mardi 3 décembre 2024 à 12h30 ET.
La présentation comprendra des réunions individuelles et sera accessible par webcast. Les parties intéressées peuvent accéder au webcast en direct via la section Investisseurs du site Web de Tectonic, où une rediffusion sera disponible pendant environ 90 jours après la conférence.
Tectonic Therapeutic (NASDAQ: TECX), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf G-Protein-gekoppelte Rezeptoren (GPCR) spezialisiert hat, hat seine Teilnahme an der 36. jährlichen Healthcare-Konferenz von Piper Sandler bekannt gegeben. Die Veranstaltung findet vom 3. bis 5. Dezember 2024 in New York statt. Alise Reicin, MD, Präsidentin und CEO, wird am Dienstag, den 3. Dezember 2024, um 12:30 Uhr ET eine Präsentation halten.
Die Präsentation umfasst Einzelgespräche und ist über einen Webcast zugänglich. Interessierte können über den Investorenbereich der Tectonic-Website auf den Live-Webcast zugreifen, der für etwa 90 Tage nach der Konferenz als Aufzeichnung verfügbar bleibt.
- None.
- None.
WATERTOWN, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will present at the Piper Sandler 36th Annual Healthcare Conference being held in New York on December 3-5, 2024.
| Piper Sandler 36th Annual Healthcare Conference details: | |
| Meetings: | Presentation and one-on-one meetings |
| Presentation Date: | Tuesday, December 3rd, 2024 |
| Presentation Time: | 12:30 PM ET |
| Presenter: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
For more information regarding one-on-one meetings, please contact your Piper Sandler representative.
The live webcast can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website at www.tectonictx.com. Once the conference has concluded, a replay of the webcast will be available on the Company’s website for approximately 90 days.
About Tectonic
Tectonic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its proprietary GEODe™ (GPCRs Engineered for Optimal Discovery) technology platform, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit www.tectonictx.com and follow on LinkedIn.
FAQ
When will Tectonic Therapeutic (TECX) present at the Piper Sandler Healthcare Conference?
How can investors access Tectonic Therapeutic's (TECX) Piper Sandler Conference presentation?
What is the focus of Tectonic Therapeutic's (TECX) research and development?
